What is NDC 51662-1581?

51662-1581 is the product NDC for Bupivacaine Hci, Bupivacaine hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupivacaine Hci?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupivacaine Hci NDC 51662-1581 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1581Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1581Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1581-3	5166215810351662158103	25 POUCH in 1 CASE (51662-1581-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1581-2) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 10, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupivacaine Hci
Generic name (nonproprietary): bupivacaine hci
Active ingredients: Bupivacaine hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Infiltration, Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207183
Marketing start: Jul 10, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1581_0f90b497-04bc-5195-e063-6294a90a2b58SPL ID 0f90b497-04bc-5195-e063-6294a90a2b58SPL set ID e37e1599-db88-2fcd-e053-2995a90a00e5RxCUI 1012396UNII 7TQO7W3VT8
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662158103 followed by a unit qualifier and the quantity

Package 51662-1581-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Bupivacaine hydrochloride injection USP is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (See WARNINGS .) Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride injection USP in these patients. Bupivacaine hydrochloride injection USP is not recommended for intravenous regional anesthesia (Bier Block). See WARNINGS\ . The routes of administration and indicated bupivacaine hydrochlo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1581

What is NDC 51662-1581?: 51662-1581 is the product NDC for Bupivacaine Hci, Bupivacaine hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupivacaine Hci.
What is the active ingredient?: Bupivacaine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupivacaine Hci?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 207183

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207183
Product	Strength	Form · route	Labeler	Product NDC
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	A-S Medication Solutions	50090-4516
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Eugia US LLC	55150-249
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	Eugia US LLC	55150-250
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Medical Purchasing Solutions, LLC	71872-7133
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	Medical Purchasing Solutions, LLC	71872-7270
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionInfiltration, Perineural	Sportpharm LLC	85766-305
BUPIVACAINE HYDROCHLORIDE injection, solution	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionPerineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1638